Sana Biotechnology, Inc. (SANA)
1.88
-0.14
(-6.93%)
USD |
NASDAQ |
Nov 16, 16:00
1.88
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Price : 1.88 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 1.99 | 2.02 | 1.87 | 1.88 | 4.352M |
| Nov 13, 2026 | 2.05 | 2.05 | 1.860 | 2.02 | 3.201M |
| Nov 12, 2026 | 2.25 | 2.25 | 2.00 | 2.01 | 3.687M |
| Nov 11, 2026 | 2.43 | 2.449 | 2.28 | 2.29 | 2.728M |
| Nov 10, 2026 | 2.42 | 2.52 | 2.31 | 2.43 | 2.538M |
| Nov 09, 2026 | 2.42 | 2.48 | 2.28 | 2.465 | 3.265M |
| Nov 06, 2026 | 2.49 | 2.49 | 2.282 | 2.37 | 2.305M |
| Nov 05, 2026 | 2.53 | 2.53 | 2.28 | 2.34 | 3.086M |
| Nov 04, 2026 | 2.55 | 2.62 | 2.455 | 2.56 | 2.643M |
| Nov 03, 2026 | 2.43 | 2.52 | 2.40 | 2.44 | 1.819M |
| Nov 02, 2026 | 2.57 | 2.585 | 2.37 | 2.40 | 2.596M |
| Oct 30, 2026 | 2.68 | 2.72 | 2.51 | 2.57 | 2.077M |
| Oct 29, 2026 | 2.655 | 2.768 | 2.65 | 2.72 | 3.309M |
| Oct 28, 2026 | 2.43 | 2.64 | 2.38 | 2.63 | 3.288M |
| Oct 27, 2026 | 2.37 | 2.48 | 2.33 | 2.47 | 2.621M |
| Oct 26, 2026 | 2.33 | 2.385 | 2.29 | 2.36 | 1.509M |
| Oct 23, 2026 | 2.35 | 2.38 | 2.245 | 2.33 | 1.708M |
| Oct 22, 2026 | 2.325 | 2.44 | 2.28 | 2.37 | 2.429M |
| Oct 21, 2026 | 2.38 | 2.39 | 2.315 | 2.35 | 2.402M |
| Oct 20, 2026 | 2.27 | 2.42 | 2.25 | 2.36 | 3.526M |
| Oct 19, 2026 | 2.32 | 2.359 | 2.22 | 2.30 | 2.629M |
| Oct 16, 2026 | 2.46 | 2.51 | 2.25 | 2.27 | 3.089M |
| Oct 15, 2026 | 2.36 | 2.51 | 2.35 | 2.475 | 2.916M |
| Oct 14, 2026 | 2.37 | 2.430 | 2.32 | 2.33 | 2.767M |
| Oct 13, 2026 | 2.60 | 2.635 | 2.37 | 2.41 | 4.911M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 9.86 |
| Twist Bioscience Corp. | 105.04 |
| Beam Therapeutics, Inc. | 20.94 |
| Revolution Medicines, Inc. | 166.87 |
| Prelude Therapeutics, Inc. | 3.41 |
Price Related Metrics
| Price to Book Value | 3.122 |
| Earnings Yield | -28.34% |
| Market Cap | 563.10M |